These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3122702)

  • 21. [Determination of clotting factor VIII activity in mammals using the one-stage clotting and the chromogenic methods].
    Lutze G; Lutze G; Kutschmann K; Schröpel M
    Berl Munch Tierarztl Wochenschr; 2002; 115(7-8):297-302. PubMed ID: 12174728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Matrix effects on proficiency testing materials. Impact on accuracy of cholesterol measurement in laboratories in the nation's largest hospital system.
    Naito HK; Kwak YS; Hartfiel JL; Park JK; Travers EM; Myers GL; Ross JW; Eckfeldt JH; Hartmann AE
    Arch Pathol Lab Med; 1993 Apr; 117(4):345-51. PubMed ID: 8466396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo recovery of factor VIII following transfusion: a survey of recent data and publications to assess the influence of standards used for potency assignment. On behalf of the Subcommittee on Factor VIII and IX of the Scientific and Standardization Committee of the ISTH.
    Prowse CV
    Thromb Haemost; 1995 Oct; 74(4):1191-6. PubMed ID: 8560434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factor VIII and factor IX Sub-Committee. Recommendations for the assay of high-purity factor VIII concentrates.
    Barrowcliffe TW
    Thromb Haemost; 1993 Nov; 70(5):876-7. PubMed ID: 8128450
    [No Abstract]   [Full Text] [Related]  

  • 25. [Determination of the factor VIII ristocetin cofactor (Willebrand factor) using a semi-quantitative slide test. Preliminary results].
    Bogaty-Yver J; Musitelli JJ; Conard J; Horellou MH; Samama M
    Ann Biol Clin (Paris); 1983; 41(5):319-24. PubMed ID: 6421207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Laboratory testing for von Willebrand's disease: an assessment of current diagnostic practice and efficacy by means of a multi-laboratory survey. RCPA Quality Assurance Program (QAP) in Haematology Haemostasis Scientific Advisory Panel.
    Favaloro EJ; Smith J; Petinos P; Hertzberg M; Koutts J
    Thromb Haemost; 1999 Oct; 82(4):1276-82. PubMed ID: 10544913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calibration of the Ph. Eur. BRP Batch 3/Mega 2 (US/FDA) standard for human coagulation factor VIII concentrate for use in the potency assay.
    Kirschbaum N; Wood L; Lachenbruch P; Weinstein M; Daas A; Rautmann G; Spieser JM; Buchheit KH
    Pharmeuropa Spec Issue Biol; 2002 Jun; 2002(1):31-64. PubMed ID: 12448031
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Problems in the standardization of Factor VIII assays.
    Kirkwood TB
    Scand J Haematol Suppl; 1980; 37():110-5. PubMed ID: 6787697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Common units for clotting factors assayed against different standards.
    North WR; Stirling Y; Meade TW
    Thromb Haemost; 1982 Dec; 48(3):270-3. PubMed ID: 6819646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chromogenic assays for equine coagulation factors VII, VIII:C, IX, and X, and C1-esterase inhibitor.
    Topper MJ; Prasse KW
    Am J Vet Res; 1998 May; 59(5):538-41. PubMed ID: 9582952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factor assay (VIII and IX) results in the College of American Pathologists Survey Program (1976-1979).
    Triplett DA; Kocoshis TA; Harms CS
    Scand J Haematol Suppl; 1980; 37():116-29. PubMed ID: 6787698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of von Willebrand disease type 2N (Normandy) in Australia: a cross-laboratory investigation using different methods.
    Rodgers SE; Lerda NV; Favaloro EJ; Duncan EM; Casey GJ; Quinn DM; Hertzberg M; Lloyd JV
    Am J Clin Pathol; 2002 Aug; 118(2):269-76. PubMed ID: 12162689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Laboratory assessment of factor VIII inhibitor titer: the North American Specialized Coagulation Laboratory Association experience.
    Peerschke EI; Castellone DD; Ledford-Kraemer M; Van Cott EM; Meijer P;
    Am J Clin Pathol; 2009 Apr; 131(4):552-8. PubMed ID: 19289591
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies of phospholipid reagents used in coagulation I: some general properties and their sensitivity to factor VIII.
    Barrowcliffe TW; Gray E
    Thromb Haemost; 1981 Oct; 46(3):629-33. PubMed ID: 6797093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Standardization of factor VIII: establishment and use of secondary standards.
    Panicucci F; Angeloni G; Arrighi S; Bucci E; DiMambro G; Lecchini L; Pitruzzello S; Positano M
    J Biol Stand; 1985 Apr; 13(2):115-21. PubMed ID: 3922990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interinstitutional comparison of bedside blood glucose monitoring program characteristics, accuracy performance, and quality control documentation: a College of American Pathologists Q-Probes study of bedside blood glucose monitoring performed in 226 small hospitals.
    Novis DA; Jones BA
    Arch Pathol Lab Med; 1998 Jun; 122(6):495-502. PubMed ID: 9625416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Standardization of Factor VIII. I. Calibration of British Standards for Factor VIII clotting activity.
    Barrowcliffe TW; Kirkwood TB
    Br J Haematol; 1980 Nov; 46(3):471-81. PubMed ID: 6778499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bedside measurement of factor VIII:C activity in individuals with hemophilia A.
    Kessler CM; Bernstein Z; Ghesani S; Shamsipour Z; Frances C; Zucker ML; LaDuca FM
    Am J Hematol; 1996 Mar; 51(3):181-5. PubMed ID: 8619397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disparity between one- and two-stage factor VIII assays in measuring VIIIC in heparinized plasma.
    Rock G; Palmer DS
    Thromb Haemost; 1985 Dec; 54(4):780-3. PubMed ID: 3937275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Flow cytometric lymphocyte subset enumeration: 10 years of external quality assessment in the Benelux countries.
    Levering WH; van Wieringen WN; Kraan J; van Beers WA; Sintnicolaas K; van Rhenen DJ; Gratama JW
    Cytometry B Clin Cytom; 2008 Mar; 74(2):79-90. PubMed ID: 17849485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.